Solaris Endovascular Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $5M

  • Investors
  • 4

Solaris Endovascular General Information

Description

Developer of endovascular services intended for vascular care and dialysis access for peripheral artery disease. The company offers medical devices designed for use in vascular procedures, serving patients with end-stage kidney disease and peripheral artery disease, enabling patients to improve vascular health.

Contact Information

Website
www.solarisendovascular.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3232 McKinney Avenue
  • Suite 500
  • Dallas, TX 75204
  • United States
+1 (215)
Primary Industry
Therapeutic Devices
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 3232 McKinney Avenue
  • Suite 500
  • Dallas, TX 75204
  • United States
+1 (215)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Solaris Endovascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Oct-2026 $5M Completed Generating Revenue
To view Solaris Endovascular’s complete valuation and funding history, request access »

Solaris Endovascular Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Solaris Endovascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240415678-A1 A drug-eluting stent comprising a biocompatible thermoplastic polymer lining and a drug- containing coating Pending 15-Jun-2023

Solaris Endovascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Solaris Endovascular Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
1839 Ventures Venture Capital Minority
IPD Capital Venture Capital Minority
The Beyond Capital Venture Capital Minority
UT Ventures Angel Group Minority
To view Solaris Endovascular’s complete investors history, request access »

Ready to get started?

Request a free trial

Solaris Endovascular FAQs

  • When was Solaris Endovascular founded?

    Solaris Endovascular was founded in 2024.

  • Where is Solaris Endovascular headquartered?

    Solaris Endovascular is headquartered in Dallas, TX.

  • What is the size of Solaris Endovascular?

    Solaris Endovascular has 6 total employees.

  • What industry is Solaris Endovascular in?

    Solaris Endovascular’s primary industry is Therapeutic Devices.

  • Is Solaris Endovascular a private or public company?

    Solaris Endovascular is a Private company.

  • What is Solaris Endovascular’s current revenue?

    The current revenue for Solaris Endovascular is .

  • How much funding has Solaris Endovascular raised over time?

    Solaris Endovascular has raised $5M.

  • Who are Solaris Endovascular’s investors?

    1839 Ventures, IPD Capital, The Beyond Capital, and UT Ventures have invested in Solaris Endovascular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process